درباره این اپیزود
In this podcast episode, Shannon Hill, Nissa Van Etten, and Jordan Fries interview Thomas Frazier about outcome measurement in behavioral intervention services. Using Frazier and colleagues' work on adaptive social communication measurement as a foundation, the discussion explores why many legacy assessments were not designed for the ABA context or for individuals with autism and developmental disabilities. The presenters distinguish between moment-to-moment ABA data collection and periodic outcome assessment, highlighting how periodic measures support long-term progress tracking, clinical decision-making, and accountability to funders. The episode emphasizes the complementary roles of norm-referenced and skill-based assessments, discusses constraints such as limited assessment authorizations, and underscores the importance of monitoring client and family quality of life. Ethical considerations related to caregiver-report measures, interpretation of sensitive results, and appropriate referrals are also addressed.
To earn CEUs for listening, click here, log in or sign up, pay the CEU fee, + take the attendance verification quiz to generate your certificate! Don't forget to subscribe and follow and leave us a rating and review.
Show Notes:
References Frazier, T. W., Youngstrom, E. A., Frazier, A. R., & Uljarevic, M. (2025). A critical appraisal of the measurement of adaptive social communication behaviors in the behavioral intervention context. Behavioral Sciences, 15(6), 722.
Aman, M. G., Singh, N. N., Stewart, A. W., & Field, C. J. (1985). The Aberrant Behavior Checklist: A behavior rating scale for the assessment of treatment effects. American Journal of Mental Deficiency, 89(5), 485–491.
Sparrow, S. S., Cicchetti, D. V., & Balla, D. A. (2005). Vineland Adaptive Behavior Scales (2nd ed.). Circle Pines, MN: American Guidance Service.
Abidin, R. R. (2012). Parenting Stress Index (4th ed.). Lutz, FL: Psychological Assessment Resources.
Resources U.S. Food and Drug Administration. (2022). Patient-Focused Drug Development: Selecting, Developing, or Modifying Fit-for-Purpose Clinical Outcome Assessments—Guidance for Industry, FDA Staff, and Other Stakeholders.
International Consortium for Health Outcomes Measurement (ICHOM). Autism Spectrum Disorder Standard Set.
Child and Family Quality of Life (CFQL) Measure.
